These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33782808)

  • 21. The sulfur microbial diet and risk of nonalcoholic fatty liver disease: a prospective gene-diet study from the UK Biobank.
    Liu Z; Huang H; Ruan J; Wang Z; Xu C
    Am J Clin Nutr; 2024 Feb; 119(2):417-424. PubMed ID: 38000660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database.
    Kumarendran B; O'Reilly MW; Manolopoulos KN; Toulis KA; Gokhale KM; Sitch AJ; Wijeyaratne CN; Coomarasamy A; Arlt W; Nirantharakumar K
    PLoS Med; 2018 Mar; 15(3):e1002542. PubMed ID: 29590099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease.
    Kim TJ; Sinn DH; Min YW; Son HJ; Kim JJ; Chang Y; Baek SY; Ahn SH; Lee H; Ryu S
    J Gastroenterol; 2017 Nov; 52(11):1201-1210. PubMed ID: 28382402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease.
    Chinnadurai R; Chrysochou C; Kalra PA
    Nephron; 2019; 141(1):24-30. PubMed ID: 30384370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.
    Fargion S; Porzio M; Fracanzani AL
    World J Gastroenterol; 2014 Oct; 20(37):13306-24. PubMed ID: 25309067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.
    Mikolasevic I; Milic S; Racki S; Zaputovic L; Stimac D; Radic M; Markic D; Orlic L
    Perit Dial Int; 2016; 36(4):427-32. PubMed ID: 26475841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Uric Acid Is a Mediator of the Association Between Obesity and Incident Nonalcoholic Fatty Liver Disease: A Prospective Cohort Study.
    Zhang Q; Ma X; Xing J; Shi H; Yang R; Jiao Y; Chen S; Wu S; Zhang S; Sun X
    Front Endocrinol (Lausanne); 2021; 12():657856. PubMed ID: 34054728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.
    Jarvis H; Craig D; Barker R; Spiers G; Stow D; Anstee QM; Hanratty B
    PLoS Med; 2020 Apr; 17(4):e1003100. PubMed ID: 32353039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease.
    Hu KC; Wang HY; Liu SC; Liu CC; Hung CL; Bair MJ; Liu CJ; Wu MS; Shih SC
    World J Gastroenterol; 2014 Jun; 20(24):7718-29. PubMed ID: 24976709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations of Unhealthy Lifestyle and Nonalcoholic Fatty Liver Disease With Cardiovascular Healthy Outcomes.
    Wu W; Ma W; Yuan S; Feng A; Li L; Zheng H; Li S; He N; Huang Y; Lyu J
    J Am Heart Assoc; 2023 Dec; 12(23):e031440. PubMed ID: 38014686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease.
    Satapathy SK; Sanyal AJ
    Semin Liver Dis; 2015 Aug; 35(3):221-35. PubMed ID: 26378640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.
    Kitae A; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
    Can J Gastroenterol Hepatol; 2019; 2019():5121574. PubMed ID: 31687367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China.
    Liang Y; Chen H; Liu Y; Hou X; Wei L; Bao Y; Yang C; Zong G; Wu J; Jia W
    J Clin Endocrinol Metab; 2022 Jan; 107(1):88-97. PubMed ID: 34508601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease.
    Henson JB; Simon TG; Kaplan A; Osganian S; Masia R; Corey KE
    Aliment Pharmacol Ther; 2020 Apr; 51(7):728-736. PubMed ID: 32043602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid Function and the Risk of Nonalcoholic Fatty Liver Disease: The Rotterdam Study.
    Bano A; Chaker L; Plompen EP; Hofman A; Dehghan A; Franco OH; Janssen HL; Darwish Murad S; Peeters RP
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3204-11. PubMed ID: 27270473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of obesity and metabolic health status in the development of non-alcoholic fatty liver disease (NAFLD): A United Kingdom population-based cohort study using the health improvement network (THIN).
    Vusirikala A; Thomas T; Bhala N; Tahrani AA; Thomas GN; Nirantharakumar K
    BMC Endocr Disord; 2020 Jun; 20(1):96. PubMed ID: 32605642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different dietary carbohydrate component intakes and long-term outcomes in patients with NAFLD: results of longitudinal analysis from the UK Biobank.
    Liu Z; Huang H; Xie J; Hou L; Xu C
    Nutr J; 2023 Dec; 22(1):67. PubMed ID: 38062487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonalcoholic Fatty Liver Disease Associates With Increased Overall Mortality and Death From Cancer, Cardiovascular Disease, and Liver Disease in Women but Not Men.
    Hwang YC; Ahn HY; Park SW; Park CY
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1131-1137.e5. PubMed ID: 29158157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk for the development of non-alcoholic fatty liver disease: A prospective study.
    Wang J; Ma L; Chen S; Xu L; Miao M; Yu C; Li Y; Xu C
    J Gastroenterol Hepatol; 2018 Aug; 33(8):1518-1523. PubMed ID: 29381226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
    Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.